| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |